Abstract
A series of 14 new compounds related to pyrazinamide were synthesized, characterized with analytical data and screened for in vitro antimycobacterial activity against Mycobacterium tuberculosis, Mycobacterium kansasii and two types of Mycobacterium avium. The series comprised of N-substituted 3-aminopyrazine- 2,5-dicarbonitriles derived from 3-chloropyrazine-2,5-dicarbonitrile by nucleophilic substitution of chlorine by various non-aromatic amines (alkylamines, cycloalkylamines and heterocyclic amines).
Noteworthy antimycobacterial activity against M. tuberculosis was found among the alkylamino derivatives, for example, 3-(heptylamino) pyrazine-2,5-dicarbonitrile inhibited M. tuberculosis at MIC = 51 mu mol/L. 3-(Hexylamino) pyrazine-2,5-dicarbonitrile inhibited M. kansasii at MIC = 218 mu mol/L. Basic structure-activity relationships are discussed.
A comparison between calculated and experimentally determined lipophilicity parameters within the series is included.